Volitionrx Ltd (New York Stock Exchange Arca:VNRX)
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Loses money on what it sells.
- Revenue
- $2.5M
- Net income
- -$25.6M
- Net margin
- -1043.1%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $12.0M
- Cash
- $2.8M
Owes more within a year than it holds to pay it.
- Current assets
- $4.1M
- Current liabilities
- $13.5M
- Current ratio
- 0.30
Consumes cash and must keep raising it.
- Operating cash flow
- -$19.4M
- Free cash flow
- -$19.4M
- FCF margin
- -790.3%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 9.2M
- Share growth (1y)
- 78.4%
- Cash runway
- 2 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
VNRX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 398.66 K | 985.08 K | 447.03 K | 627.28 K | 406.69 K | 246.38 K |
| Revenue Growth (YoY) | -1.97 % | 299.81 % | 133.25 % | 32.19 % | 2.75 % | 43.64 % |
| Cost of Revenue | 0.00 | 254.41 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 398.66 K | 730.66 K | 447.03 K | 627.28 K | 406.69 K | 246.38 K |
| SG&A Expense | 2.75 M | 3.48 M | 2.76 M | 3.40 M | 3.94 M | 3.11 M |
| R&D Expense | 1.80 M | 2.85 M | 2.47 M | 2.29 M | 2.72 M | 2.61 M |
| Operating Expenses | 4.55 M | 6.08 M | 5.18 M | 5.73 M | 6.70 M | 5.77 M |
| Operating Income | -4.16 M | -5.35 M | -4.73 M | -5.10 M | -6.30 M | -5.52 M |
| Pretax Income | -7.32 M | -6.70 M | -6.30 M | -5.41 M | -6.31 M | -5.48 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -7.33 M | -6.66 M | -6.27 M | -5.38 M | -6.28 M | -5.42 M |
| EPS (Basic) | -0.85 | -0.97 | -1.05 | -1.00 | -1.22 | -1.12 |
| EPS (Diluted) | -0.85 | -0.97 | -1.05 | -1.00 | -1.22 | -1.12 |
| Shares Outstanding | 9.15 M | 6.88 M | 5.34 M | 5.41 M | 5.13 M | 4.83 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.